FDA Cleared
New Device
Pathway: 510K
Minder® System
Applicant:
Epi-Minder Pty, Ltd.
Statutory Profile
Legal Standard:
Substantial Equivalence (SE) to predicate (21 CFR 807)
Product Code:
SEM
Review Panel:
Neurology
21 CFR Regulation:
8
Review Velocity Metrics
Date Received:
2026-07-08
Decision Date:
2026-10-29
Total Review Duration:
113 calendar days (113 days)
Official FDA Research Backlinks
Direct links to primary official records hosted by the U.S. Food and Drug Administration CDRH databases:
Identified Contacts & Correspondents
Tracy Cameron
Role: SUBMITTER_CONTACT
Notice a discrepancy or outdated information on this record?
Report to support@fdacleared.org